Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Cash from Investing Activities: 2010-2025

Historic Cash from Investing Activities for Exponent (EXPO) over the last 13 years, with Oct 2025 value amounting to -$2.7 million.

  • Exponent's Cash from Investing Activities fell 56.07% to -$2.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$9.3 million, marking a year-over-year decrease of 48.18%. This contributed to the annual value of -$6.9 million for FY2025, which is 57.58% up from last year.
  • According to the latest figures from Q4 2025, Exponent's Cash from Investing Activities is -$2.7 million, which was down 17.63% from -$2.3 million recorded in Q3 2025.
  • In the past 5 years, Exponent's Cash from Investing Activities registered a high of $28.3 million during Q3 2021, and its lowest value of -$26.2 million during Q4 2021.
  • In the last 3 years, Exponent's Cash from Investing Activities had a median value of -$2.3 million in 2025 and averaged -$2.7 million.
  • Data for Exponent's Cash from Investing Activities shows a peak YoY increase of 87.80% (in 2022) and a maximum YoY decrease of 120.87% (in 2022) over the last 5 years.
  • Exponent's Cash from Investing Activities (Quarterly) stood at $23.6 million in 2021, then plummeted by 112.43% to -$2.9 million in 2022, then surged by 34.11% to -$1.9 million in 2023, then soared by 48.15% to -$1.7 million in 2024, then plummeted by 56.07% to -$2.7 million in 2025.
  • Its Cash from Investing Activities was -$2.7 million in Q4 2025, compared to -$2.3 million in Q3 2025 and -$1.8 million in Q2 2025.